Hereditary renal cancers

Radiology

Volumn 226, Issue 1, 2003, Pages 33-46

  Choyke, Peter L ^a   Glenn, Gladys M ^a   Walther, McClellan M ^a   Zbar, Berton ^b   Linehan, W Marston ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiomyolipoma; Genes and genetics; Kidney neoplasms; Kidney, CT; Sclerosis, tuberous; State of the Art; Von Hippel Lindau disease

Indexed keywords

ANGIOMYOLIPOMA; ARTICLE; BIRT HOGG DUBE SYNDROME; CANCER PREVENTION; CATHETER ABLATION; CHROMOSOME TRANSLOCATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DIAGNOSTIC IMAGING; FAMILIAL CANCER; GENE MUTATION; GENETICS; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY TUMOR; LEIOMYOMA; MEDULLARY CARCINOMA; NEPHRECTOMY; ONCOCYTOMA; ONSET AGE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SURGICAL APPROACH; TUBEROUS SCLEROSIS; VON HIPPEL LINDAU DISEASE;

CARCINOMA, MEDULLARY; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; TUBEROUS SCLEROSIS;

EID: 0037254446     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2261011296     Document Type: Article

References (123)

1. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol 2000; 27:115-123.
2. Godley PA, Ataga KI. Renal cell carcinoma. Curr Opin Oncol 2000; 12:260-264.
3. American Cancer Society. Cancer facts and figures 2002. Available at: www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pdf. Accessed, October, 16, 2002.
4. Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Family history and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2001; 10:1001-1004.
5. Peltonen L, McKusick VA. Genomics and medicine: dissecting human disease in the postgenomic era. Science 2001; 291:1224-1229.
6. Maher ER, Iselius L, Yates JR, et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28:443-447.
7. Zbar B. Inherited epithelial tumors of the kidney: old and new diseases. Semin Cancer Biol 2000; 10:313-318.
8. Phillips JL, Pavlovich CP, Walther M, Ried T, Linehan WM. The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy. Curr Opin Urol 2001; 11:463-469.
9. Knudson AG Jr. Genetics of human cancer. Genetics 1975; 79(suppl):305-316.
10. Sgambati MT, Stolle C, Choyke PL, et al. Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 2000; 66:84-91.
11. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183:131-133.
12. Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: workgroup no. 1 - Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80:987-989.
13. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997; 21:621-635.
14. Choyke PL, Walther MM, Glenn GM, et al. Imaging features of hereditary papillary renal cancers. J Comput Assist Tomogr 1997; 21:737-741.
15. Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24:835-842.
16. Nagashima Y. Chromophobe renal cell carcinoma: clinical, pathological and molecular biological aspects. Pathol Int 2000; 50:872-878.
17. Amin MB, Crotty TB, Tickoo SK, Farrow GM. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 1997; 21:1-12.
18. Eble JN, Hull MT. Morphologic features of renal oncocytoma: a light and electron microscopic study. Hum Pathol 1984; 15:1054-1061.
19. Noguchi S, Nagashima Y, Shuin T, et al. Renal oncocytoma containing "chromophobe" cells. Int J Urol 1995; 2:279-280.
20. Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol 1998; 15:21-40.
21. Csanaky G, Szereday Z, Magyarlaki T, Mehes G, Herbert T, Buzogany I. Renal angiomyolipoma: report of three cases with regional lymph node involvement and/or with renal cell carcinoma. Tumori 1995; 81:469-474.
22. Honda N, Matsuoka K, Fujimoto K, et al. Renal angiomyolipoma extending into inferior vena cava: MR demonstration. J Comput Assist Tomogr 1993; 17:161-162.
23. Collins ET. Two cases, brother and sister, with peculiar vascular new growth, probably primarily retinal, affecting both eyes. Trans Ophthalmol Soc 1894; 14:141-145.
24. von Hippel E. Uber eine sehr self seltene erkrankung der netzhaut. Klinische Beobachtungen Archive fur Ophthalmologie 1904; 59:83-106.
25. Lindau A. Studien ber kleinbirncysten bau: pathogenese und beziehungen zur angiomatosis rentinae. Acta Radiol et Microbiol Scandinavica Suppl 1926; 1:1-128.
26. Melmon KL, Rosen SW. Lindau's disease. Am J Med 1964; 36:595-617.
27. Seizinger BR, Rouleau GA, Ozelius LJ, et al. von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988; 332:268-269.
28. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260:1317-1320.
29. Kaelin WG, Iliopoulos O, Lonergan KM, Ohh M. Functions of the von hippel-Lindau tumour suppressor protein. J Intern Med 1998; 243:535-539.
30. Zhu H, Bunn HF. Signal transduction: how do cells sense oxygen? Science 2001; 292:449-451.
31. Kondo K, Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene. Exp Cell Res 2001; 264:117-125.
32. Ohh M, Kaelin WG Jr. The von Hippel-Lindau tumour suppressor protein: new perspectives. Mol Med Today 1999; 5:257-563.
33. Bindra RS, Vasselli JR, Stearman R, Linehan WM, Klausner RD. VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells. Cancer Res 2002; 62: 3014-3019.
34. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998; 12: 417-423.
35. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel Lindau disease: genetic, clinical, and imaging features. Radiology 1995; 194:629-635.
36. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994; 54:2852-2855.
37. Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshida O. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res 1991; 51:949-953.
38. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991; 337:1052-1054.
39. Maher ER, Kaelin WG Jr. von Hippel-Lindau disease. Medicine (Baltimore) 1997; 76:381-391.
40. Libutti SK, Choyke PL, Bartlett DL, et al. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 1998; 124:1153-1159.
41. Aprill BS, Drake AJ III, Lasseter DH, Shakir KM. Silent adrenal nodules in von Hippel-Lindau disease suggest pheochromocytoma. Ann Intern Med 1994; 120:485-487.
42. Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis and treatment. World J Urol 1999; 17:35-39.
43. Glenn GM, Gnarra JR, Choyke PL, Walther MM, Zbar B, Linehan WM. The molecular genetics of renal cell carcinoma. In: Raghaven D, Scher HI, Lange PH, eds. Principles and practice of genitourinary oncology. Philadelphia, Pa: Lippincott-Raven, 1997; 85-97.
44. Poston CD, Jaffe GS, Lubensky IA, et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. J Urol 1995; 153:22-26.
45. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 1995; 154: 2010-2014.
46. Walther MM, Choyke PL, Glenn G, et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 1999; 161: 1475-1479.
47. Turner KJ, Huson SM, Moore N, Britton BJ, Cranston D. von Hippel-Lindau disease: renal tumors less than 3 cm can metastasize. J Urol 2001; 165:1207.
48. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 2001; 165:777-781.
49. Gomez MR. History of the tuberous sclerosis complex. Brain Dev 1995; 17:55-57.
50. Chan HS, Daneman A, Gribbin M, Martin DJ. Renal cell carcinoma in the first two decades of life. Pediatr Radiol 1983; 13:324-328.
51. Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP. Tuberous sclerosis associated renal cell carcinoma: clinical, pathological, and genetic features. Am J Pathol 1996; 149:1201-1208.
52. Torres VE, Zincke H, King BK, Bjornsson J. Renal manifestations of tuberous sclerosis complex. Contrib Nephrol 1997; 122:64-75.
53. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000; 107:97-114.
54. Torres VE, Bjornsson J, Zincke H. Inherited renal neoplasms. J Nephrol 1998; 11:229-238.
55. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277:805-808.
56. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 2000; 97:6085-6090.
57. Dorkin TJ, Robson CN, Neal DE. The molecular pathology of urological malignancies. J Pathol 1997; 183:380-387.
58. Steiner MS, Goldman SM, Fishman EK, Marshall FF. The natural history of renal angiomyolipoma. J Urol 1993; 150:1782-1786.
59. Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol 1986; 135:1121-1124.
60. Bernstein J. Renal cystic disease in the tuberous sclerosis complex. Pediatr Nephrol 1993; 7:490-495.
61. Robertson FM, Cendron M, Klauber GT, Harris BH. Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg 1996; 1996:729-730.
62. Kulkarni S, Uddar M, Deshpande SG, Vaid S, Wadia RS. Renal cell carcinoma as significant manifestation of tuberous sclerosis complex. J Assoc Physicians India 2000; 48:351-353.
63. Sampson JR, Patel A, Mee AD. Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family. J Med Genet 1995; 32:848-850.
64. Washecka R, Hanna M. Malignant renal tumors in tuberous sclerosis. Urology 1991; 37:340-343.
65. Eker R, Mossige J, Johannessen JV, Aars H. Hereditary renal adenomas and adenocarcinomas in rats. Diagn Histopathol 1981; 4:99-110.
66. Peccatori I, Pitingolo F, Battini G, et al. Pulmonary lymphangioleiomyomatosis and renal papillary cancer: incomplete expression of tuberous sclerosis? Nephrol Dial Transplant 1997; 12:2740-1743.
67. Hidai H, Chiba T, Takagi Y, Taki A, Nagashima Y, Kuroko K. Bilateral chromophobe cell renal carcinoma in tuberous sclerosis complex. Int J Urol 1997; 4:86-89.
68. Jimenez RE, Eble JN, Reuter VE, et al. Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Pathol 2001; 14:157-163.
69. Green JAS. Renal oncocytoma and tuberous sclerosis. S African Med J 1987; 71:47-48.
70. Pea M, Bonetti F, Martignoni G, et al. Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 1998; 22:180-187.
71. Lemaitre L, Claudon M, Dubrulle F, Mazeman E. Imaging of angiomyolipomas. Semin Ultrasound CT MR 1997; 18: 100-114.
72. Lemaitre L, Robert Y, Dubrulle F, et al. Renal angiomyolipoma: growth followed up with CT and/or US. Radiology 1995; 197:598-602.
73. Aoyama T, Fujikawa K, Yoshimura K, Sasaki M, Itoh T. Bilateral renal cell carcinoma in a patient with tuberous sclerosis. In J Urol 1996; 3:150-151.
74. Zbar B, Tory K, Merino M, et al. Hereditary papillary renal cell carcinoma. J Urol 1994; 151:561-566.
75. Zbar B, Glenn G, Lubensky I, et al. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 1995; 153:907-912.
76. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 1997; 16:68-73.
77. Balint I, Fischer J, Ljungberg B, Kovacs G. Mapping the papillary renal cell carcinoma gene between loci D17S787 and D17S1799 on chromosome 17q21.32. Lab Invest 1999; 79:1713-1718.
78. Ishikawa I, Kovacs G. High incidence of papillary renal cell carcinomas in patients on chronic haemodialysis. Histopathology 1993; 22:135-139.
79. Chudek J, Herbers J, Wilhelm M, et al. The genetics of renal tumors in end-stage renal failure differs from those occurring in the general population. J Am Soc Nephrol 1998; 9:1045-1051.
80. Hughson MD, Bigler S, Dickman K, Kovacs G. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol 1999; 12:301-309.
81. Kovacs G. High frequency of papillary renal-cell tumours in end-stage kidneys: is there a molecular genetic explanation? Nephrol Dial Transplant 1995; 10: 593-596.
82. Bard RH, Lord B, Fromowitz F. Papillary adenocarcinoma of kidney. II. Radiographic and biologic characteristics. Urology 1982; 19:16-20.
83. Becker JA, Fleming R, Kanter I, Melicow M. Misleading appearances in renal angiography. Radiology 1967; 88:691-700.
84. Goldman HJ, Mitty HA. Hypovascular renal neoplasms: diagnostic considerations. Urology 1973; 1:214-217.
85. Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet 1995; 51:127-131.
86. Kiuru M, Launonen V, Hietala M, et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol 2001; 159:825-829.
87. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002; 30:406-410.
88. Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 2001; 98:3387-3392.
89. Birt AR, Hogg GR, Dube WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 1977; 113:1674-1677.
90. Roth JS, Rabinowitz AD, Benson M, Grossman ME. Bilateral renal cell carcinoma in the Birt-Hogg-Dube syndrome. J Am Acad Dermatol 1993; 29:1055-1056.
91. Nickerson ML, Warren MB, Toro JR, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects and benign tumors of the hair follicle in patients with Birt-Hogg-Dube syndrome. Cancer Cell 2002; 2:157-164.
92. Toro JR, Glenn G, Duray P, et al. Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 1999; 135:1195-1202.
93. Schulz T, Hartschuh W. Birt-Hogg-Dube syndrome and Hornstein-Knickenberg syndrome are the same: different sectioning technique as the cause of different histology. J Cutan Pathol 1999; 26: 55-61.
94. Erlandson RA, Shek TW, Reuter VE. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. Ultrastruct Pathol 1997; 21:409-417.
95. Weirich G, Glenn G, Junker K, et al. Familial renal oncocytoma: clinicopathological study of 5 families. J Urol 1998; 160:335-340.
96. Warfel KA, Eble JN. Renal oncocytomatosis. J Urol 1982; 127:1179-1180.
97. Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, Davis CJ Jr. Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 1993; 186: 693-696.
98. Cohen AJ, Li FP, Berg S, et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301:592-595.
99. Seizinger BR, Smith DI, Filling-Katz MR, et al. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci U S A 1991; 88:2864-2868.
100. Lynch HT, Rozen P, Schuelke GS. Hereditary colon cancer: polyposis and non-polyposis variants. CA Cancer J Clin 1985; 35:95-114.
101. Lynch HT, Lynch JF. Genetics of colonic cancer. Digestion 1998; 59:481-492.
102. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64:430- 433.
103. Mecklin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991; 68:1109-1112.
104. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 1996; 78:1149-1167.
105. Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol 2000; 18:305-313.
106. Rohde D, Jakse G. Involvement of the urogenital tract in patients with five or more separate malignant neoplasms: case and review. Eur Urol 1998; 34:512-517.
107. Renkonen-Sinisalo L, Aarnio M, Mecklin JP, Jarvinen HJ. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 2000; 24:137-142.
108. Davis CJ Jr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995; 19:1-11.
109. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000; 63:205-211.
110. Pickhardt PJ. Renal medullary carcinoma: an aggressive neoplasm in patients with sickle cell trait. Abdom Imaging 1998; 23:531-532.
111. Adsay NV, deRoux SJ, Sakr W, Grignon D. Cancer as a marker of genetic medical disease: an unusual case of medullary carcinoma of the kidney. Am J Surg Pathol 1998; 22:260-264.
112. Avery RA, Harris JE, Davis CJ Jr, Borgaonkar DS, Byrd JC, Weiss RB. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer 1996; 78:128-132.
113. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol 2000; 151:839-845.
114. Davidson AJ, Choyke PL, Hartman DS, Davis CJ Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 1995; 195:83-85.
115. Pickhardt PJ, Siegel CL, McLarney JK. Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol 2001; 176:627-633.
116. Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (≤3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996; 198:785-788.
117. Choyke PL, Pavlovich CP, Daryanani KD, Hewitt SM, Linehan WM, Walther MM. Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience. J Urol 2001; 165:397-400.
118. Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217:665-672.
119. Walther MC, Shawker TH, Libutti SK, et al. A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J Urol 2000; 163:1424-1427.
120. Gill IS, Novick AC, Meraney AM, et al. Laparoscopic renal cryoablation in 32 patients. Urology 2000; 56:748-753.
121. Remer EM, Weinberg EJ, Oto A, O'Malley CM, Gill IS. MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol 2000; 174:635-640.
122. Chen RN, Novick AC, Gill IS. Laparoscopic cryoablation of renal masses. Urol Clin North Am 2000; 27:813-820.
123. Rassweiler JJ, Abbou C, Janetschek G, Jeschke K. Laparoscopic partial nephrectomy: the European experience. Urol Clin North Am 2000; 27:721-736.